Moderna stock sinks as patent case spurs concern for COVID-19 vaccine AstraZeneca, Lilly, GSK and more will share COVID antibody secrets to speed manufacturing scale-up PwC: Deals among providers, payers slowed in first half of 2020 due to COVID-19 Columbia team pinpoints potent antibody cocktail for COVID-19 Novavax, Fujifilm lock up supply for late-stage COVID-19 vaccine trial Hackensack Meridian Health, Maimonides Medical Center piloting sensor-embedded clothing for COVID-19 patients Roche says COVID-19 tests helped offset 2020 losses in routine health checks FiercePharmaAsia—CanSino's COVID-19 vaccine data; AZ-SK supply deal; Chinese hackers Meet the executive who will be leading Cigna's plans for Medicare Advantage expansion Biopharma roundup: Roche touts diagnostic sales amid pandemic slump; Quest, LabCorp struggle with testing turnaround Healthcare roundup: HHS renews public health emergency declaration Featured Story | By Nick Paul Taylor A patent court has sided with Arbutus Biopharma in its dispute with Moderna, raising concerns that the intellectual property dispute could stymie COVID-19 vaccine development. The news sent shares in Moderna down 9% despite it being unclear whether the patent is relevant to its COVID-19 vaccine. read more |
| |
|---|
|
Top Stories By Fraiser Kansteiner Six drugmakers working on COVID-19 antibody treatments want to swap information and scale up production before those therapies win approval—and now they have Justice Department approval to share their need-to-know secrets. read more By Robert King A new report from PwC found that deal activity declined in the first half of the year in the health services industry due in part to the COVID-19 pandemic. read more By Angus Liu Researchers at Columbia University have isolated a cocktail of antibodies from COVID-19 patients they say could offer a new and potentially potent option for treating and preventing the disease. Some of the antibodies target areas of SARS-CoV-2 that are not addressed by drugs currently in development, they said. read more By Kyle Blankenship Maryland biotech Novavax scored a big leg up in its hunt for a COVID-19 vaccine with a major infusion from the Trump administration this month. Now, Novavax is using some of those funds to help supply doses for a pivotal late-stage trial down the road. read more By Heather Landi Two New York City-metro health systems are collaborating with Nanowear to research the use of a sensor-embedded undergarment to monitor COVID-19 patients. Find out why Meridian Health Systems and Maimonides Medical Center see the startup's technology as a promising tool to aid in COVID-19 diagnosis. read more By Conor Hale Despite its first overall quarterly sales decline in nearly a decade—dragged down by the global spread of COVID-19, as well as biosimilars encroaching on three of its top-selling cancer drugs—the pandemic has still been a boost for Roche’s diagnostics division. read more By Angus Liu CanSino Biolgocis' adenovirus-vectored COVID-19 vaccine induced antibody and T-cell responses in mid-phase trial. AstraZeneca signs COVID-19 vaccine production deal with SK Bioscience. U.S. accuses two Chinese hackers of targeting COVID-19-related researches. And more. read more By Paige Minemyer Cigna is moving full speed ahead with significant expansion in the Medicare Advantage market and has tapped a new exec to spearhead that effort. read more By Eric Sagonowsky, Angus Liu, Kyle Blankenship, Conor Hale, Fraiser Kansteiner Demand for coronavirus testing saw Roche's diagnostic sales rise. States and major pharmacy chains are seeking testing alternatives as labs like Quest and LabCorp struggle to process results quickly. And researchers created a version of the virus' spike protein that could speed up vaccine production. Plus, Fauci thinks schools should reopen on a regional basis. read more By Healthcare Staff Follow along with the latest COVID-19 news straight from the Fierce Healthcare team. read more |
